INC Research Holdings Inc
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with… Read more
INC Research Holdings Inc (INCR) - Total Liabilities
Latest total liabilities as of June 2025: $319.52 Million USD
Based on the latest financial reports, INC Research Holdings Inc (INCR) has total liabilities worth $319.52 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
INC Research Holdings Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how INC Research Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
INC Research Holdings Inc Competitors by Total Liabilities
The table below lists competitors of INC Research Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
The LEADCORP Inc
KQ:012700
|
Korea | ₩595.00 Billion |
|
A1 Yenilenebilir Enerji Üretim A.S.
IS:A1YEN
|
Turkey | TL965.35 Million |
|
Kyung Nong Corporation
KO:002100
|
Korea | ₩250.09 Billion |
|
flyExclusive, Inc.
NYSE MKT:FLYX
|
USA | $524.27 Million |
|
RAIZ Invest Ltd
AU:RZI
|
Australia | AU$6.78 Million |
|
Integra Indocabinet Tbk PT
JK:WOOD
|
Indonesia | Rp3.14 Trillion |
|
Beforepay Group Ltd
AU:B4P
|
Australia | AU$36.29 Million |
|
Cambuci S.A
SA:CAMB3
|
Brazil | R$85.66 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down INC Research Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INC Research Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INC Research Holdings Inc (2011–2024)
The table below shows the annual total liabilities of INC Research Holdings Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $364.90 Million | +10.73% |
| 2023-12-31 | $329.55 Million | -24.51% |
| 2022-12-31 | $436.53 Million | +92.19% |
| 2021-12-31 | $227.13 Million | +564.88% |
| 2020-12-31 | $34.16 Million | +31.23% |
| 2019-12-31 | $26.03 Million | +60.12% |
| 2018-12-31 | $16.26 Million | +397.63% |
| 2017-12-31 | $3.27 Million | -10.88% |
| 2016-12-31 | $3.67 Million | +449.16% |
| 2015-12-31 | $667.52K | -65.65% |
| 2014-12-31 | $1.94 Million | -13.50% |
| 2013-12-31 | $2.25 Million | -52.13% |
| 2012-12-31 | $4.69 Million | -91.41% |
| 2011-12-31 | $54.64 Million | -- |